23 Aug 2024 --- Norway-based bioactive marine ingredients innovator Hofseth Biocare (HBC) reports gross operating revenues of NOK 80.4 million (US$7.6 million) for Q2 and NOK 132.8 million (US$13 million) for the first half of the year.